Procedure
cytokine therapy
cytokine therapy is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
50%
Ph phase_2
1
25%
Ph phase_3
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(1)
Other(2)
Detailed Status
Withdrawn1
Suspended1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Trials by Status
withdrawn125%
suspended125%
completed125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection
NCT00111397
unknownphase_1
Biological Therapy in Treating Women With Metastatic Breast Cancer
NCT00002780
suspendedphase_3
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
NCT00324831
withdrawnphase_2
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
NCT00017160
Clinical Trials (4)
Showing 4 of 4 trials
NCT00111397Phase 1
Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection
NCT00002780Phase 1
Biological Therapy in Treating Women With Metastatic Breast Cancer
NCT00324831Phase 3
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
NCT00017160Phase 2
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4